## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w
Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
β Scribed by V. Espeli; E. Zucca; M. Ghielmini; O. Giannini; A. Salatino; F. Martucci; A. Richetti
- Book ID
- 113834128
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 235 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1368-8375
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de
## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5βfluorouracil (5βFU) and cisplatin has increased acute toxicities as well as survival. Onceβweekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we